国际精神病学杂志JOURNALOFINTERNATIONALPSYCHIATRY2023年第50卷第3期-462-◎临床研究◎Clinicalresearch焦点解决团体治疗联合艾司西酞普兰对抑郁障碍患者心理弹性和希望水平的影响段登艾、王维、张勇辉、张婧、谢长翼、韦海龙【摘要】目的探讨焦点解决团体治疗（SolutionFocusedGrouptherapy，SFGT）联合艾司西酞普兰与单一服用艾司西酞普兰对抑郁障碍患者心理弹性和希望水平的影响。方法选取符合《国际疾病分类（第10版）》抑郁障碍诊断标准的84例患者，随机分入联合组和对照组，开展为期8周的治疗。采用心理弹性量表（theConnor-DavidsonResilienceScale，CDRISC）和希望水平量表（HerthHopeIndex，HHI）进行效果评价，并使用SPSS22.0进行数据分析。结果8周治疗结束后，联合组脱落8例，对照组脱落10例，2组在基线时CDRISC、HHI总分及维度分均无差异，治疗4周时、8周时CDRISC、HHI总分及维度分联合组均高于对照组，且具有统计学意义（P<0.05）。结论SFGT联合艾司西酞普兰治疗对抑郁障碍患者心理弹性和希望水平的疗效比单一服用艾司西酞普兰治疗效果更好。【关键词】焦点解决团体治疗；艾司西酞普兰；抑郁障碍；心理弹性；希望水平【中图分类号】R749.055【文献标识码】A【文章编号】1673-2952（2023）03-0462-04EffectofResilienceandHopeLevelsinpatientswithdepresseddisordersbysolutionfocusedgroupther-apycombinedwithEscitalopramDUANDeng'ai，WANGWei，ZHANGYonghui，etal.YunnanPsychiatricHospital，Kunming650224，China【Abstract】ObjectiveTofocusonthedifferencebetweensolutionfocusedgrouptherapy（SFGT）com-binedwithEscitalopramandonlyuseEscitalopraminthetreatmentofdepressiongroup.Methods84patientswhometthediagnosticcriteriaofICD-10depressionwererandomlydividedintocombinedtreatmentgroupandsimpledruggroup.TheeffectwasevaluatedbytheConnor-DavidsonResilienceScale（CDRISC）andHerthHopeIndex（HHI）.ResultsTherewasnodifferenceinthesubscalesandtotalscoresofCDRISCandHHIbetweenthetwogroupsbeforetreatment.ThetotalscoresandsubscalesscoresofCDRISCandHHIwerehigherthanthoseofthecon-trolgroupatthe4thand8thweekinthecourseoftreatment，andthedifferencewasstatisticallysignificant（P<0.05）.ConclusionSFGTcombinedwithEcitalopramismoreeffectivethanmonotherapyforthelevelofresilienceand...
